If you are wondering whether DexCom stock still offers value after a choppy few years, this article walks through what the ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and Bernstein lowered their price targets on the stock, citing concerns over the ...
Revenue for the quarter reached $1.26 billion, which also surpassed the anticipated $1.24 billion. Despite these positive financial results, DexCom’s stock experienced a decline in after-hours trading ...
Shares of DexCom (NASDAQ: DXCM) jumped 9.9% on Monday after rising more than 12% earlier in the day. The nice gain appears to be related to a couple of factors. Currently, the CGM system integrates ...
Insulet (PODD) stock and DexCom (DXCM) receive new Buy ratings from Deutsche Bank while Tandem Diabetes Care (TNDM) stock ...
Zacks Investment Research on MSN

Here's why DexCom (DXCM) is a strong growth stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.
DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose monitoring (CGM) market. A strong third-quarter 2025 performance and a series ...
Despite the positive earnings report, several analyst firms have adjusted their stock price targets for DexCom. BTIG lowered its price target to $85 from $109, citing growth concerns, though it ...
DexCom, Inc. DXCM reported first-quarter 2026 adjusted earnings per share (EPS) of 56 cents, which beat the Zacks Consensus Estimate of 47 cents by 19.2%. The company reported adjusted EPS of 32 cents ...